{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:32:52Z","timestamp":1793338372409,"version":"4.5.0"},"reference-count":383,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018978","name":"Indian Institute of Technology Ropar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023000","name":"Yenepoya University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115274","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:34:07Z","timestamp":1787614447000},"page":"115274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PA","title":["Living drug carriers: Microbial and bioengineered platforms redefining precision therapeutic and immunomodulatory delivery"],"prefix":"10.1016","volume":"399","author":[{"given":"Lahanya","family":"Guha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6684-6744","authenticated-orcid":false,"given":"Jonaid Ahmad","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2312-9734","authenticated-orcid":false,"given":"Bipasha","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115274_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107086","article-title":"Biologics, theranostics, and personalized medicine in drug delivery systems","volume":"201","author":"Puccetti","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1603658","article-title":"Microbial metabolite-driven immune reprogramming in tumor immunotherapy: mechanisms and therapeutic perspectives","volume":"16","author":"Lu","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115274_bb0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12016-023-08958-0","article-title":"The evolving landscape of fecal microbial transplantation","volume":"65","author":"Shao","year":"2023","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"10.1016\/j.jconrel.2026.115274_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s42004-025-01491-5","article-title":"Towards precision medicine using biochemically triggered cleavable conjugation","volume":"18","author":"Parshad","year":"2025","journal-title":"Communications Chemistry"},{"key":"10.1016\/j.jconrel.2026.115274_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/EBC20253042","article-title":"Immunomodulation: precision targeting for restoring immune homeostasis and therapeutic applications","volume":"69","author":"Xu","year":"2025","journal-title":"Essays Biochem."},{"key":"10.1016\/j.jconrel.2026.115274_bb0030","article-title":"Programming tissue-sensing T cells that deliver therapies to the brain","volume":"386","author":"Simic","year":"2024","journal-title":"Science (1979)"},{"key":"10.1016\/j.jconrel.2026.115274_bb0035","article-title":"Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs","volume":"386","author":"Reddy","year":"2024","journal-title":"Science (1979)"},{"key":"10.1016\/j.jconrel.2026.115274_bb0040","article-title":"Living drugs: a wonderful evolution for therapeutic applications","volume":"1","author":"Chintalapati","year":"2025","journal-title":"Cell Biomater."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115274_bb0045","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s44222-024-00198-x","article-title":"Engineering cells for therapy and diagnosis","volume":"9","author":"Li","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.115274_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20240045","article-title":"Synthetic biology-based engineering living therapeutics for antimicrobial application","volume":"5","author":"Huang","year":"2025","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2026.115274_bb0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115274_bb0060","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1038\/s41467-022-33491-7","article-title":"Programmable self-regulated molecular buffers for precise sustained drug delivery","volume":"13","author":"Desrosiers","year":"2022","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115274_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2020","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.jconrel.2026.115274_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115274_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-025-04305-6","article-title":"Bioresponsive engineered nanoparticles for immunomodulation","volume":"23","author":"Hegde","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40291-024-00695-0","article-title":"Clostridium bacteria: harnessing tumour necrosis for targeted gene delivery","volume":"28","author":"Theys","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb0085","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1073\/pnas.251543698","article-title":"Combination bacteriolytic therapy for the treatment of experimental tumors","volume":"98","author":"Dang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2026.115274_bb0090","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0406242101","article-title":"Bacteriolytic therapy can generate a potent immune response against experimental tumors","volume":"101","author":"Agrawal","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115274_bb0095","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1038\/s41598-020-60396-6","article-title":"Development of oxytolerant Salmonella typhimurium using Radiation Mutation Technology (RMT) for cancer therapy","volume":"10","author":"Gao","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115274_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00203-025-04417-w","article-title":"Therapeutic engineering of the gut microbiome using synthetic biology and metabolic tools: a comprehensive review with E. coli Nissle 1917 as a model case study","volume":"207","author":"Sadhu","year":"2025","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20240095","article-title":"Synthetic biology-based engineering cells for drug delivery","volume":"5","author":"Yi","year":"2025","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2026.115274_bb0110","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1021\/acssynbio.3c00232","article-title":"Algorithmic programming of sequential logic and genetic circuits for recording biochemical concentration in a probiotic bacterium","volume":"12","author":"Lebovich","year":"2023","journal-title":"ACS Synth. Biol."},{"issue":"2022","key":"10.1016\/j.jconrel.2026.115274_bb0115","first-page":"858","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115274_bb0120","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1021\/acssynbio.0c00444","article-title":"Living therapeutics: the next frontier of precision medicine","volume":"9","author":"Kelly","year":"2020","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70057","article-title":"Living engineered bacterial therapeutics: emerging affordable precision interventions","volume":"17","author":"Srivastava","year":"2024","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0130","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s40200-023-01279-1","article-title":"Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives","volume":"22","author":"Guo","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.jconrel.2026.115274_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14001","article-title":"Engineering bacteria to modulate host metabolism","volume":"238","author":"Ciocan","year":"2023","journal-title":"Acta Physiol (Oxford)"},{"key":"10.1016\/j.jconrel.2026.115274_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb0145","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41571-023-00803-9","article-title":"Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors","volume":"10","author":"Simpson","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.jconrel.2026.115274_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41586-025-09913-z","article-title":"Microbiota-induced T cell plasticity enables immune-mediated tumour control","volume":"651","author":"Najar","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115274_bb0155","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jconrel.2026.115274_bb0160","article-title":"Engineered nano-bacteria hybrids for precision cancer immunotherapy","volume":"35","author":"Yu","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb0165","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/s41467-020-16602-0","article-title":"Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity","volume":"11","author":"Leventhal","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0170","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an engineered E. coli Nissle strain expressing STING agonist, with and without Atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb0175","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.fmre.2024.11.001","article-title":"Engineered bacteria: strategies and applications in cancer immunotherapy","volume":"5","author":"Zhang","year":"2024","journal-title":"Fundam. Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb0180","doi-asserted-by":"crossref","first-page":"10503","DOI":"10.1038\/s41467-024-54883-x","article-title":"Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy","volume":"15","author":"Wu","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.71157","article-title":"Advancements in immunomodulatory therapies for IBD and their interplay with the gut\u2013brain axis: an updated review of current literature and beyond","volume":"8","author":"Jha","year":"2025","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115274_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","article-title":"Multifunctional nanoparticle-mediated combining therapy for human diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb0195","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.3390\/ijms26178143","article-title":"Cell-based drug delivery systems: innovative drug transporters for targeted therapy","volume":"26","author":"Sergazy","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0200","article-title":"Genetically modified Lactococcus lactis for delivery of human Interleukin-10 to dendritic cells","volume":"2012","author":"Braat","year":"2011","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.jconrel.2026.115274_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176286","article-title":"Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU","volume":"12","author":"Durrer","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jconrel.2026.115274_bb0210","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3389\/fimmu.2018.02318","article-title":"Commensal Escherichia coliStrains can promote intestinal inflammation via differential interleukin-6 production","volume":"9","author":"Kittana","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2025.103269","article-title":"Engineered microbial living matter for diagnostics, prevention, and therapy","volume":"92","author":"Khazem","year":"2025","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0220","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.tibtech.2024.06.011","article-title":"Engineered bacterial therapeutics with material solutions","volume":"42","author":"Dey","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0225","article-title":"Biohybrid materials: structure design and biomedical applications","volume":"16","author":"Wang","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2016.04.032","article-title":"Microbiome therapeutics \u2013 advances and challenges","volume":"105","author":"Mimee","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb0235","article-title":"Microbiome therapeutics: exploring the present scenario and challenges","volume":"10","author":"Yadav","year":"2021","journal-title":"Gastroenterol. Rep. (Oxf.)"},{"key":"10.1016\/j.jconrel.2026.115274_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.38212\/2224-6614.3540","article-title":"Regulatory framework and challenges for live biotherapeutic products in Taiwan","volume":"33","author":"Pan","year":"2025","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.jconrel.2026.115274_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114364","article-title":"Engineered microbial systems for advanced drug delivery","volume":"187","author":"Shen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.870675","article-title":"Engineered bacteria-based living materials for biotherapeutic applications","volume":"10","author":"Omer","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0255","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1039\/D4NR05298F","article-title":"Advanced disease therapeutics using engineered living drug delivery systems","volume":"17","author":"Mamidi","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115274_bb0260","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jare.2025.10.028","article-title":"Programmable microbial therapeutics: advances in engineered bacteria for targeted in vivo delivery and precision medicine","volume":"85","author":"Zhao","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb0265","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/1751-7915.13820","article-title":"Programming living sensors for environment, health and biomanufacturing","volume":"14","author":"Wan","year":"2021","journal-title":"J. Microbial. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2025.12.001","article-title":"Live biotherapeutics: emerging trends and future directions in microbial therapy","volume":"220","author":"Kandiyal","year":"2026","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0275","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.1007\/s00253-020-10902-7","article-title":"Towards next-generation model microorganism chassis for biomanufacturing","volume":"104","author":"Liu","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s44222-025-00354-x","article-title":"Non-model bacteria as platforms for endogenous gene expression in synthetic biology","volume":"4","author":"Poppeliers","year":"2025","journal-title":"Nature Reviews Bioengineering"},{"issue":"2026","key":"10.1016\/j.jconrel.2026.115274_bb0285","first-page":"729","article-title":"Implantable living materials autonomously deliver therapeutics using contained engineered bacteria","volume":"392","author":"Harimoto","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115274_bb0290","first-page":"327","article-title":"Two-component regulatory systems in microbial pathogenesis","author":"Jagtap","year":"2024","journal-title":"Industr. Microbiol. Biotechnol. Insight Curr. Trends"},{"key":"10.1016\/j.jconrel.2026.115274_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111502","article-title":"An atlas of bacterial two-component systems reveals function and plasticity in signal transduction","volume":"41","author":"Xie","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115274_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.118036","article-title":"Synthetic biology-driven biosensors for healthcare applications: a roadmap toward programmable and intelligent diagnostics","volume":"291","author":"Sarac","year":"2026","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2026.115274_bb0305","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ymthe.2025.11.013","article-title":"Recent advances of engineered bacteria for therapeutic applications","volume":"34","author":"Xiang","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108733","article-title":"Microbial quorum sensing: mechanisms, applications, and challenges","volume":"86","author":"Ruan","year":"2026","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2026.115274_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2024.100194","article-title":"From formulation to function: a detailed review of microbial biofilms and their polymer-based extracellular substances","volume":"5","author":"Saharan","year":"2024","journal-title":"Microbe"},{"key":"10.1016\/j.jconrel.2026.115274_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/1462-2920.70250","article-title":"Resilient communities: the role of biofilms in Salmonella enterica ecology, persistence and pathogenesis","volume":"28","author":"Avc\u0131","year":"2026","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2026.103447","article-title":"Controlling biofilm dynamics to unlock the future of biofilm-based biocatalysis","volume":"98","author":"Liu","year":"2026","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0330","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-023-06288-x","article-title":"Evolution of a minimal cell","volume":"620","author":"Moger-Reischer","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115274_bb0335","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/s41467-019-10673-4","article-title":"Minimal exposure of lipid II cycle intermediates triggers cell wall antibiotic resistance","volume":"10","author":"Piepenbreier","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0340","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0345","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1021\/acssynbio.2c00079","article-title":"A framework for the systematic selection of biosensor chassis for environmental synthetic biology","volume":"11","author":"Sridhar","year":"2022","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0350","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13036-025-00526-8","article-title":"Modular and signal-responsive transcriptional regulation using CRISPRi-aided genetic switches in Escherichia coli","volume":"19","author":"Kim","year":"2025","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.jconrel.2026.115274_bb0355","first-page":"479","article-title":"Codon-usage bias and genomic architecture of 79 psoriasis-susceptibility genes: implications for expression efficiency and therapeutic targeting","volume":"15","author":"Jiang","year":"2025","journal-title":"Psoriasis (Auckl)."},{"key":"10.1016\/j.jconrel.2026.115274_bb0360","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13068-021-02013-w","article-title":"Oxidative stress tolerance contributes to heterologous protein production in Pichia pastoris","volume":"14","author":"Lin","year":"2021","journal-title":"Biotechnol. Biofuels"},{"key":"10.1016\/j.jconrel.2026.115274_bb0365","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1039\/D1FO03896F","article-title":"A randomised, double-blind, placebo-controlled trial of Bifidobacterium bifidum CCFM16 for manipulation of the gut microbiota and relief from chronic constipation","volume":"13","author":"Wang","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2026.115274_bb0370","article-title":"Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies","volume":"18","author":"Chen","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb0375","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4014\/jmb.2207.07047","article-title":"Safety assessment systems for microbial starters derived from fermented foods","volume":"32","author":"Heo","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0380","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.0.000715.v4","article-title":"Safety assessment of five candidate probiotic lactobacilli using comparative genome analysis","volume":"6","author":"Altavas","year":"2024","journal-title":"Access Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1579175","article-title":"Whole genome sequencing reveals virulence\u2013mobile element linkages and phylogenetic diversity in multidrug-resistant Escherichia coli from Nigeria","volume":"16","author":"Medugu","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0390","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12864-021-07539-9","article-title":"Whole-genome analysis of probiotic product isolates reveals the presence of genes related to antimicrobial resistance, virulence factors, and toxic metabolites, posing potential health risks","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jconrel.2026.115274_bb0395","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/microorganisms13020388","article-title":"Genomic insights into probiotic Lactococcus lactis T-21, a wild plant-associated lactic acid bacterium, and its preliminary clinical safety for human application","volume":"13","author":"Fukao","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.jconrel.2026.115274_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108336","article-title":"Next generation probiotics: engineering live biotherapeutics","volume":"72","author":"Murali","year":"2024","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2026.115274_bb0405","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tips.2022.02.002","article-title":"Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics","volume":"43","author":"Lynch","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0410","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41467-024-44776-4","article-title":"Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia","volume":"15","author":"Gurbatri","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb0415","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/ijms21030990","article-title":"Engineering biology to construct microbial chassis for the production of difficult-to-express proteins","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102254","article-title":"Protocol for engineering E. coli Nissle 1917 to diagnose, record, and ameliorate inflammatory bowel disease in mice","volume":"4","author":"Zou","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.jconrel.2026.115274_bb0425","article-title":"Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies","volume":"18","author":"Chen","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb0430","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/microorganisms10010047","article-title":"Genomic features and construction of streamlined genome chassis of nisin z producer Lactococcus lactis n8","volume":"10","author":"Qiao","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.jconrel.2026.115274_bb0435","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1038\/s41467-022-31614-8","article-title":"Transcriptional programming in a bacteroides consortium","volume":"13","author":"Huang","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0440","article-title":"Design patterns for engineering genetic stability","volume":"19","author":"Son","year":"2021","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115274_bb0445","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41589-024-01817-9","article-title":"Population-level amplification of gene regulation by programmable gene transfer","volume":"21","author":"Son","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0450","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2859-11-11","article-title":"Low-mutation-rate, reduced-genome Escherichia coli: an improved host for faithful maintenance of engineered genetic constructs","volume":"11","author":"Cs\u00f6rgo","year":"2012","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.jconrel.2026.115274_bb0455","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41467-017-00063-z","article-title":"Insulated transcriptional elements enable precise design of genetic circuits","volume":"8","author":"Zong","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0460","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chom.2013.08.003","article-title":"Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis","volume":"14","author":"Molloy","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.115274_bb0465","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.2147\/IJN.S338272","article-title":"Innovative approaches of engineering tumor-targeting bacteria with different therapeutic payloads to fight cancer: a smart strategy of disease management","volume":"16","author":"Allemailem","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115274_bb0470","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/pharmaceutics14102100","article-title":"Salmonella as a promising curative tool against cancer","volume":"14","author":"Aganja","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115274_bb0475","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.gendis.2016.01.003","article-title":"Clostridium novyi-NT in cancer therapy","volume":"3","author":"Staedtke","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.jconrel.2026.115274_bb0480","article-title":"Escherichia coli on colorectal cancer: a two-edged sword","volume":"17","author":"Jian","year":"2024","journal-title":"J. Microbial. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0485","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-food-061120-014739","article-title":"Gut colonization mechanisms of lactobacillus and: an argument for personalized designs","volume":"12","author":"Xiao","year":"2021","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0490","article-title":"Dynamic evolution of the tumor immune microenvironment in malignant tumors and emerging therapeutic paradigms","volume":"6","author":"Sun","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.jconrel.2026.115274_bb0495","article-title":"Surface modification of probiotics at single-cell resolution: strategies, applications, and future directions in inflammatory bowel disease","volume":"35","author":"Peng","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1586195","article-title":"Machine learning integrates region-specific microbial signatures to distinguish geographically adjacent populations within a province","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0505","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3390\/microorganisms13112521","article-title":"Probiotic potential of traditional and emerging microbial strains in functional foods: from characterization to applications and health benefits","volume":"13","author":"Uhegwu","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.jconrel.2026.115274_bb0510","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.7150\/thno.103983","article-title":"Engineered probiotic-based biomaterials for inflammatory bowel disease treatment","volume":"15","author":"Sang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115274_bb0515","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1186\/s12967-025-07271-y","article-title":"Engineered probiotics: a new era in treating inflammatory bowel disease","volume":"23","author":"Duan","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb0520","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s44324-025-00066-1","article-title":"Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes","volume":"3","author":"Jyoti","year":"2025","journal-title":"Npj Metabolic Health and Disease"},{"key":"10.1016\/j.jconrel.2026.115274_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1651965","article-title":"A comprehensive overview of the effects of probiotics, prebiotics and synbiotics on the gut-brain axis","volume":"16","author":"Kezer","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0530","doi-asserted-by":"crossref","DOI":"10.69936\/en11y0024","article-title":"Synthetic biology-enabled engineering of probiotics for precision and targeted therapeutic delivery applications","volume":"1","author":"Patra","year":"2024","journal-title":"Exon"},{"key":"10.1016\/j.jconrel.2026.115274_bb0535","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.jconrel.2026.115274_bb0540","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115274_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1327464","article-title":"Bifidobacterium longum suppresses colorectal cancer through the modulation of intestinal microbes and immune function","volume":"15","author":"Shang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0550","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0555","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.7150\/thno.103983","article-title":"Engineered probiotic-based biomaterials for inflammatory bowel disease treatment","volume":"15","author":"Sang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115274_bb0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/mi.2009.116","article-title":"Orally administered L. lactis secreting an anti-TNF nanobody demonstrate efficacy in chronic colitis","volume":"3","author":"Bouma","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0565","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nbt.4222","article-title":"Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria","volume":"36","author":"Isabella","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0570","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tips.2022.02.002","article-title":"Emerging strategies for engineering E. coli Nissle 1917-based therapeutics","volume":"43","author":"Lynch","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0575","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymgme.2018.06.002","article-title":"Phenylalanine ammonia lyase (PAL): from discovery to enzyme substitution therapy for phenylketonuria","volume":"124","author":"Levy","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2026.115274_bb0580","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11427-021-2137-3","article-title":"Expression of phenylalanine ammonia lyase as an intracellularly free and extracellularly cell surface-immobilized enzyme on a gut microbe as a live biotherapeutic for phenylketonuria","volume":"66","author":"Jiang","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0585","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb0590","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/bios15090556","article-title":"Synthetic gene circuits enable sensing in engineered living materials","volume":"15","author":"Cai","year":"2025","journal-title":"Biosensors (Basel)."},{"key":"10.1016\/j.jconrel.2026.115274_bb0595","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201900319","article-title":"Biosensing in smart engineered probiotics","volume":"15","author":"Rottinghaus","year":"2020","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2026.115274_bb0600","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202406486","article-title":"Self-adjusting engineered probiotic for targeted tumor colonization and local therapeutics delivery","volume":"12","author":"Zou","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0605","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1039\/D4SC08228A","article-title":"Logic-gated approach for targeted delivery and site-selective activation of photothermal agents in precision cancer treatment","volume":"16","author":"Jiang","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0610","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00203-025-04417-w","article-title":"Therapeutic engineering of the gut microbiome using synthetic biology and metabolic tools: a comprehensive review with E. coli Nissle 1917 as a model case study","volume":"207","author":"Sadhu","year":"2025","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0615","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1038\/s41467-024-51496-2","article-title":"Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade","volume":"15","author":"Holzgruber","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb0620","article-title":"Engineered bacteria for disease diagnosis and treatment using synthetic biology","volume":"18","author":"Jin","year":"2025","journal-title":"J. Microbial. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0625","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-7799(00)01542-0","article-title":"Redox-operated genetic switches: the SoxR and OxyR transcription factors","volume":"19","author":"Pomposiello","year":"2001","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0630","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/antiox14010094","article-title":"Hypoxia-induced reactive oxygen species: their role in cancer resistance and emerging therapies to overcome it","volume":"14","author":"Mendoza","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.jconrel.2026.115274_bb0635","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jconrel.2026.115274_bb0640","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1038\/s41467-024-54260-8","article-title":"Highly multiplexed design of an allosteric transcription factor to sense new ligands","volume":"15","author":"Nishikawa","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1425529","article-title":"Therapeutic applications of synthetic gene\/genetic circuits: a patent review","volume":"12","author":"Carneiro","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0650","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jcyt.2025.06.014","article-title":"Detailed analysis of the effects of a NOT gate on activation and growth of T cells","volume":"27","author":"Ando","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jconrel.2026.115274_bb0655","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1038\/ncomms11658","article-title":"Synthetic mixed-signal computation in living cells","volume":"7","author":"Rubens","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005125","article-title":"Data-driven metabolic pathway compositions enhance cancer survival prediction","volume":"12","author":"Auslander","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0665","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115274_bb0670","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jbiotec.2025.07.007","article-title":"Novel approaches to engineering autolysis: a scalable alternative for recovery of bioproducts","volume":"406","author":"Jonsson","year":"2025","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0675","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.copbio.2020.05.006","article-title":"Engineering microbial diagnostics and therapeutics with smart control","volume":"66","author":"Amrofell","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0680","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1038\/s41467-024-48606-5","article-title":"Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb0685","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12934-024-02566-z","article-title":"Engineering of bacteria towards programmed autolysis: why, how, and when?","volume":"23","author":"Dong","year":"2024","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.jconrel.2026.115274_bb0690","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1371596","article-title":"Codon-optimization in gene therapy: promises, prospects and challenges","volume":"12","author":"Paremskaia","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0695","article-title":"Accelerated design of Escherichia coli reduced genomes using a whole-cell model and machine learning","volume":"16","author":"Gherman","year":"2025","journal-title":"Cell Syst."},{"key":"10.1016\/j.jconrel.2026.115274_bb0700","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-025-60233-2","article-title":"Metabolic modeling reveals a multi-level deregulation of host-microbiome metabolic networks in IBD","volume":"16","author":"Taubenheim","year":"2025","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0705","doi-asserted-by":"crossref","first-page":"30591","DOI":"10.1038\/srep30591","article-title":"Engineering Salmonella as intracellular factory for effective killing of tumour cells","volume":"6","author":"Camacho","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.jconrel.2026.115274_bb0710","article-title":"Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases","volume":"2011","author":"de LeBlanc","year":"2011","journal-title":"ISRN Gastroenterol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0715","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1675065","article-title":"Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers","volume":"16","author":"Zeng","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0720","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11427-021-2137-3","article-title":"Expression of phenylalanine ammonia lyase as an intracellularly free and extracellularly cell surface-immobilized enzyme on a gut microbe as a live biotherapeutic for phenylketonuria","volume":"66","author":"Jiang","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb0725","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgme.2005.06.016","article-title":"Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?","volume":"86","author":"Sarkissian","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2026.115274_bb0730","doi-asserted-by":"crossref","DOI":"10.4292\/wjgpt.v16.i4.110271","article-title":"Targeting gut microbiota in liver disease: a pharmacological approach for hepatic encephalopathy and beyond","volume":"16","author":"Vargas-Beltran","year":"2025","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb0735","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i3.104167","article-title":"Gut microbiota in the development and progression of chronic liver diseases: gut microbiota-liver axis","volume":"17","author":"Yakut","year":"2025","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100104","article-title":"Synergistic combinations of antimicrobial peptides and conventional antibiotics: a strategy to delay resistance emergence in World Health Organization priority bacteria","volume":"78","author":"Roque-Borda","year":"2026","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb0745","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3389\/fmicb.2015.01020","article-title":"On Lactococcus lactis UL719 competitivity and nisin (Nisaplin\u00ae) capacity to inhibit Clostridium difficile in a model of human colon","volume":"6","author":"Le Lay","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0750","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1038\/s41467-024-50591-8","article-title":"A bacteriocin expression platform for targeting pathogenic bacterial species","volume":"15","author":"Rutter","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0755","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tibtech.2023.06.012","article-title":"The expanded CRISPR toolbox for constructing microbial cell factories","volume":"42","author":"Teng","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0760","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-025-00882-9","article-title":"CRISPR-engineered microbiome: living therapeutics revolutionize blood cancer immunotherapy","author":"Cheng","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.jconrel.2026.115274_bb0765","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s12276-025-01500-6","article-title":"Applications of multiplexed CRISPR\u2013Cas for genome engineering","volume":"57","author":"Cheng","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb0770","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41586-024-07681-w","article-title":"In situ targeted base editing of bacteria in the mouse gut","volume":"632","author":"Br\u00f6del","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115274_bb0775","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1038\/s41467-024-52976-1","article-title":"Rewiring native post-transcriptional global regulators to achieve designer, multi-layered genetic circuits","volume":"15","author":"Simmons","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0780","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02459-23","article-title":"Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia","volume":"11","author":"Zhang","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.jconrel.2026.115274_bb0785","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/intbio\/zyab015","article-title":"Creation of a synthesis-friendly inflammation-inducible promoter suitable for cell therapy","volume":"13","author":"Jadav","year":"2021","journal-title":"Integr. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0790","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1038\/s41467-020-18008-4","article-title":"A machine learning automated recommendation tool for synthetic biology","volume":"11","author":"Radivojevi\u0107","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108592","article-title":"Tracking inflammation status for improving patient prognosis: a review of current methods, unmet clinical needs and opportunities","volume":"82","author":"Raju","year":"2025","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2026.115274_bb0800","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe1767","article-title":"Optimized gene expression from bacterial chromosome by high-throughput integration and screening","volume":"7","author":"Saleski","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115274_bb0805","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/aem.57.9.2677-2682.1991","article-title":"Chromosomal integration of plasmid DNA by homologous recombination in Enterococcus faecalis and Lactococcus lactis subsp. lactis hosts harboring Tn919","volume":"57","author":"Casey","year":"1991","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0810","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209584","article-title":"Precision design of stable genetic circuits carried in highly-insulated E. coli genomic landing pads","volume":"16","author":"Park","year":"2020","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0815","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nchembio.1979","article-title":"\u201cDeadman\u201d and \u201cpasscode\u201d microbial kill switches for bacterial containment","volume":"12","author":"Chan","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0820","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s42994-020-00030-1","article-title":"Genome recoding strategies to improve cellular properties: mechanisms and advances","volume":"2","author":"Singh","year":"2020","journal-title":"ABIOTECH"},{"key":"10.1016\/j.jconrel.2026.115274_bb0825","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.molcel.2017.10.033","article-title":"Rational design of evolutionarily stable microbial kill switches","volume":"68","author":"Stirling","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2026.115274_bb0830","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1426107","article-title":"GenoMine: a CRISPR-Cas9-based kill switch for biocontainment of Pseudomonas putida","volume":"12","author":"Asin-Garcia","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0835","doi-asserted-by":"crossref","DOI":"10.1093\/femsec\/fiaa115","article-title":"Auxotrophic interactions: a stabilizing attribute of aquatic microbial communities?","volume":"96","author":"Johnson","year":"2020","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0840","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf5851","article-title":"Synthetic auxotrophy remains stable after continuous evolution and in coculture with mammalian cells","volume":"7","author":"Kunjapur","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115274_bb0845","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7975","article-title":"Coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans","volume":"11","author":"Kurtz","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb0850","article-title":"Detecting horizontal gene transfer among microbiota: an innovative pipeline for identifying co-shared genes within the mobilome through advanced comparative analysis","volume":"12","author":"Schwarzerova","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.jconrel.2026.115274_bb0855","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34878","article-title":"Organisms with alternative genetic codes resolve unassigned codons via mistranslation and ribosomal rescue","volume":"7","author":"Ma","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2026.115274_bb0860","first-page":"67","article-title":"Metagenomics for drug discovery: antimicrobials","volume":"23","author":"Taglialegna","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0865","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3934\/microbiol.2025042","article-title":"Engineered bacteria as living therapeutics: next-generation precision tools for health, industry, environment, and agriculture","volume":"11","author":"Zalila-Kolsi","year":"2025","journal-title":"AIMS Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0870","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.it.2023.05.002","article-title":"Conditioning of the immune system by the microbiome","volume":"44","author":"Graham","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0875","article-title":"Innate immune regulation of adaptive immunity: mechanisms, implications, and bias","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0880","first-page":"1","article-title":"Engineered bacteria and bacteria-derived nanomaterials for cancer therapy: mechanisms, designs and advances","volume":"55","author":"Cheng","year":"2026","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115274_bb0885","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"1 6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb0890","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2023","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.jconrel.2026.115274_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100079","article-title":"The complement system: biology, pathology, and therapeutic interventions","volume":"77","author":"Li","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2025.102695","article-title":"Engineering microbes to modulate innate immune signaling: strategies for host\u2013microbe interactions","volume":"89","author":"Bonanno","year":"2026","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0905","series-title":"The First Line of Defence: Insights into Mechanisms and Relevance of Phagocytosis in Epithelial Cells","author":"G\u00fcnther","year":"2026"},{"key":"10.1016\/j.jconrel.2026.115274_bb0910","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","article-title":"Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets","volume":"10","author":"Guan","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jconrel.2026.115274_bb0915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004651","article-title":"Neutrophils: between host defence, immune modulation, and tissue injury","volume":"11","author":"Kruger","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2026.115274_bb0920","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cytogfr.2007.01.002","article-title":"Interplay of pathogens, cytokines and other stress signals in the regulation of dendritic cell function","volume":"18","author":"Sabatt\u00e9","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb0925","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jconrel.2026.115274_bb0930","article-title":"Dendritic cells: origin, classification, development, biological functions, and therapeutic potential","volume":"6","author":"Jin","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.jconrel.2026.115274_bb0935","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0940","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1593338","article-title":"B cell development: transcriptional regulation and immunological mechanisms in homeostasis","volume":"16","author":"G\u00f3mez-Manr\u00edquez","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0945","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1038\/s41598-025-95664-w","article-title":"Metagenomic evaluation, antimicrobial activities, and immune stimulation of probiotics from dietary supplements and dairy products","volume":"15","author":"Chornchoem","year":"2025","journal-title":"Scientific Reports"},{"key":"10.1016\/j.jconrel.2026.115274_bb0950","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2006-03-011353","article-title":"Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients","volume":"108","author":"Banerjee","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115274_bb0955","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3934\/microbiol.2025042","article-title":"Engineered bacteria as living therapeutics: next-generation precision tools for health, industry, environment, and agriculture","volume":"11","author":"Zalila-Kolsi","year":"2025","journal-title":"AIMS Microbiology"},{"key":"10.1016\/j.jconrel.2026.115274_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1689714","article-title":"Innate immunity in tumors: roles and therapeutic targets","volume":"16","author":"Leng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb0965","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.jconrel.2026.115274_bb0970","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/cells14040283","article-title":"Molecular mechanisms of immune regulation: a review","volume":"14","author":"Arneth","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115274_bb0975","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/microorganisms13112516","article-title":"Gut microbiome and immune system crosstalk in chronic inflammatory diseases: a narrative review of mechanisms and therapeutic opportunities","volume":"13","author":"Feng","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.jconrel.2026.115274_bb0980","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clicom.2026.04.003","article-title":"Gut barrier integrity and systemic immunity: mechanisms linking microbiota, barrier dysfunction, and extra-intestinal disease","volume":"9","author":"Mukherjee","year":"2026","journal-title":"Clin. Immunol. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb0985","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12964-025-02494-4","article-title":"Postbiotics as microbial-derived therapeutics for wound healing disorders: from molecular mechanisms to future application","volume":"23","author":"Dini\u0107","year":"2025","journal-title":"Cell Communication and Signaling"},{"key":"10.1016\/j.jconrel.2026.115274_bb0990","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb0995","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00281-025-01066-5","article-title":"Emerging microbiome-directed therapies in inflammatory bowel disease: beyond diet modification and FMT","volume":"47","author":"Quiroga-Centeno","year":"2025","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1000","article-title":"Engineering bacteria as living therapeutics in cancer therapy","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb1005","article-title":"Recent advances of engineered bacteria for therapeutic applications","volume":"0","author":"Xiang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb1010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1698158","article-title":"Synthetic biology approaches to enhance cancer immune responses","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1015","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3390\/cancers16172971","article-title":"Towards understanding tumour colonisation by probiotic bacterium E. coli Nissle 1917","volume":"16","author":"Radford","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115274_bb1020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1278011","article-title":"Listeria monocytogenes: a promising vector for tumor immunotherapy","volume":"14","author":"Ding","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3892\/ol.2020.12371","article-title":"Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors","volume":"21","author":"Feng","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2026.115274_bb1030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2024.03.003","article-title":"Hypoxia-targeting bacteria in cancer therapy","volume":"100","author":"Staedtke","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/antib14030052","article-title":"Fragment-based immune cell engager antibodies in treatment of cancer, infectious and autoimmune diseases: lessons and insights from clinical and translational studies","volume":"14","author":"Yang","year":"2025","journal-title":"Antibodies"},{"key":"10.1016\/j.jconrel.2026.115274_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123629","article-title":"Eliminating intratumoral bacteria with cGAS-STING-activating nanodrug-bacteria biohybrids potentiates cancer immunotherapy","volume":"325","author":"Zhou","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115274_bb1045","article-title":"Overcoming resistance to PD-1 and CTLA-4 blockade mechanisms and therapeutic strategies","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bidere.2025.100039","article-title":"Recent advances of engineered probiotics for therapeutic applications","volume":"7","author":"Zhang","year":"2025","journal-title":"BioDesign Research"},{"key":"10.1016\/j.jconrel.2026.115274_bb1055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2023.02.001","article-title":"ECM-targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models","volume":"355","author":"Kim","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115274_bb1060","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an engineered E. coli Nissle strain expressing STING agonist, with and without Atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb1065","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of bacteria for cancer immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb1070","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.fmre.2024.11.001","article-title":"Engineered bacteria: strategies and applications in cancer immunotherapy","volume":"5","author":"Zhang","year":"2025","journal-title":"Fundam. Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb1075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13059-026-03951-0","article-title":"Rational engineering of combinatorial bacterial therapies for cancer","volume":"27","author":"Steppe","year":"2026","journal-title":"Genome Biology"},{"key":"10.1016\/j.jconrel.2026.115274_bb1080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00203-026-05030-1","article-title":"Bioengineered bacteria in cancer immunotherapy: mechanistic advances, therapeutic strategies and clinical potential","volume":"208","author":"Vadakkan","year":"2026","journal-title":"Archives of Microbiology"},{"key":"10.1016\/j.jconrel.2026.115274_bb1085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jconrel.2026.115274_bb1090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-025-02343-3","article-title":"Oncolytic viruses: advanced strategies in cancer therapy","volume":"11","author":"Xiao","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb1095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-025-02335-3","article-title":"Microbiota in cancer: current understandings and future perspectives","volume":"11","author":"Yao","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb1100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-025-01268-6","article-title":"Harnessing the microbiome for cancer therapy","volume":"24","author":"Hajjar","year":"2026","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118559","article-title":"Bacteria-mediated cancer therapy (BMCT): therapeutic applications, clinical insights, and the microbiome as an emerging hallmark of cancer","volume":"192","author":"Jayaprakash","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.115274_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107882","article-title":"Immunomodulatory role of gut microbiota in autoimmune disorders and the advancement of gut microbiota based therapeutic strategies","volume":"207","author":"Fatima","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jconrel.2026.115274_bb1115","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.2147\/CCID.S559957","article-title":"Clinical treatment and clinical application research progress of psoriasis and intestinal microbiota dysbiosis","volume":"18","author":"Zhao","year":"2025","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1120","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221115312","article-title":"Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations","volume":"15","author":"Bezzio","year":"2022","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bpg.2017.09.017","article-title":"Intervening in disease through genetically-modified bacteria","volume":"31","author":"Ferreira","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1130","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3390\/biom15081165","article-title":"Effect of nematodes-bacteria complex metabolites on cancer and tumor progression","volume":"15","author":"Bahar","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.115274_bb1135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jconrel.2026.115274_bb1140","article-title":"Lactobacillus: friend or foe for systemic lupus erythematosus?","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3746\/pnf.2024.29.1.1","article-title":"Engineered probiotics for the management of congenital metabolic diseases: a systematic review","volume":"29","author":"Barati","year":"2024","journal-title":"Prev. Nutr. Food Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb1150","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1038\/s41467-021-26524-0","article-title":"Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering","volume":"12","author":"Adolfsen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1155","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02828-24","article-title":"Oral delivery of GLP-1 peptide using recombinant Lactobacillus gasseri for the treatment of type 2 diabetes mellitus","volume":"13","author":"Ke","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.jconrel.2026.115274_bb1160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jconrel.2026.115274_bb1165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12938\/bmfh.18-032","article-title":"The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms","volume":"38","author":"Jasirwan","year":"2019","journal-title":"Biosci. Microbiota Food Health"},{"key":"10.1016\/j.jconrel.2026.115274_bb1170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s43556-025-00307-1","article-title":"Microbiota\u2013gut\u2013brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets","volume":"6","author":"Chen","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.jconrel.2026.115274_bb1175","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/biomedicines10020436","article-title":"Role of microbiota-gut-brain Axis in regulating dopaminergic signaling","volume":"10","author":"Hamamah","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2026.115274_bb1180","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1629349","article-title":"Neuroplasticity and the microbiome: how microorganisms influence brain change","volume":"16","author":"Al Noman","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1185","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2576657","article-title":"Unraveling multiple sclerosis: a hidden interaction between intestinal microbiota and host lipid metabolism","volume":"17","author":"Cen","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jconrel.2026.115274_bb1190","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/biomedicines9111734","article-title":"Special delEVery: extracellular vesicles as promising delivery platform to the brain","volume":"9","author":"Pauwels","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2026.115274_bb1195","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/1751-7915.12783","article-title":"Microbial approaches for targeting antibiotic-resistant bacteria","volume":"10","author":"Wong","year":"2017","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1200","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.idc.2025.07.007","article-title":"Microbiome therapeutics for Clostridioides difficile infection","volume":"39","author":"Lucky","year":"2025","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2026.115274_bb1205","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.molmed.2021.03.009","article-title":"Topical microbial therapeutics against respiratory viral infections","volume":"27","author":"Spacova","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb1210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11904-019-00441-w","article-title":"HIV and the gut microbiota: composition, consequences, and avenues for amelioration","volume":"16","author":"Vujkovic-Cvijin","year":"2019","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.jconrel.2026.115274_bb1215","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.2023.4314","article-title":"VE303, a defined bacterial consortium, for prevention of recurrent clostridioides difficile infection: a randomized clinical trial","volume":"329","author":"Louie","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2026.115274_bb1220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/sb500090b","article-title":"Modified lactic acid Bacteria detect and inhibit multiresistant enterococci","volume":"4","author":"Borrero","year":"2014","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1225","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/s41467-023-37789-y","article-title":"Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1230","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.990875","article-title":"Engineering recombinantly expressed lectin-based antiviral agents","volume":"12","author":"Maier","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1235","doi-asserted-by":"crossref","DOI":"10.1038\/s44259-025-00125-z","article-title":"Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals","volume":"3","author":"Aw","year":"2025","journal-title":"Npj Antimicrobials and Resistance"},{"key":"10.1016\/j.jconrel.2026.115274_bb1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2022.102170","article-title":"Treatment of respiratory viral infections through inhalation therapeutics: challenges and opportunities","volume":"77","author":"Nainwal","year":"2022","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb1245","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb1250","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18991","article-title":"Chronic kidney disease and gut microbiota","volume":"9","author":"Amini Khiabani","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2026.115274_bb1255","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1186\/s12967-025-07224-5","article-title":"A systematic review of TMAO, microRNAs, and the oral\/gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities","volume":"23","author":"La Motte","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb1260","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2011.05.084","article-title":"Nitric oxide counters the inhibitory effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation","volume":"409","author":"Kharait","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/nu7010017","article-title":"The impact of diet and lifestyle on gut microbiota and human health","volume":"7","author":"Conlon","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2026.115274_bb1270","article-title":"Recent advances in responsive hydrogels for diabetic wound healing","volume":"18","author":"Zhang","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb1275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12223-022-01030-y","article-title":"Anti-inflammatory and wound healing properties of lactic acid bacteria and its peptides","volume":"68","author":"Saravanan","year":"2023","journal-title":"Folia Microbiol. (Praha)"},{"key":"10.1016\/j.jconrel.2026.115274_bb1280","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/biom15111613","article-title":"Antimicrobial peptides for skin wound healing","volume":"15","author":"Wu","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.115274_bb1285","first-page":"514","article-title":"Engineering the next generation of theranostic biomaterials with synthetic biology","volume":"32","author":"Wang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115274_bb1290","article-title":"Reactive-oxygen-species-scavenging nanomaterials for resolving inflammation","volume":"11","author":"Huang","year":"2021","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb1295","first-page":"1","article-title":"Natural and biological products therapeutic potential in restoring gut microbiome: mechanistic insights and clinical implications","volume":"2025","author":"Shanmukha","year":"2025","journal-title":"Probiotics and Antimicrobial Proteins"},{"key":"10.1016\/j.jconrel.2026.115274_bb1300","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ymgme.2022.09.012","article-title":"Altered gut microbiome diversity and function in patients with propionic acidemia","volume":"137","author":"Tims","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jconrel.2026.115274_bb1305","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.chom.2024.02.008","article-title":"Conquering homocystinuria with engineered probiotics","volume":"32","author":"Fishbein","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.115274_bb1310","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1038\/s41467-022-30880-w","article-title":"Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in mice","volume":"13","author":"Pontoizeau","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7975","article-title":"An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans","volume":"11","author":"Kurtz","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb1320","article-title":"Characterizing the microbial consortium L1 capable of efficiently degrading chlorimuron-ethyl via metagenome combining 16S rDNA sequencing","volume":"13","author":"Li","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1754-1611-4-15","article-title":"Bioresponsive matrices in drug delivery","volume":"4","author":"You","year":"2010","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.jconrel.2026.115274_bb1330","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1021\/acs.biomac.9b01341","article-title":"Adaptive polymeric assemblies for applications in biomimicry and nanomedicine","volume":"20","author":"Altay","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115274_bb1335","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12951-023-02112-w","article-title":"Marine biomaterials in biomedical nano\/micro-systems","volume":"21","author":"Wang","year":"2023","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/j.jconrel.2026.115274_bb1340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126501","article-title":"Advances in metal ion\u2013mediated macromolecular drug delivery","volume":"689","author":"Li","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115274_bb1345","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.matt.2024.01.004","article-title":"Macrophage-derived biomimetic nanoparticles for light-driven theranostics toward Mpox","volume":"7","author":"Wang","year":"2024","journal-title":"Matter"},{"key":"10.1016\/j.jconrel.2026.115274_bb1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115579","article-title":"Designing live bacterial therapeutics for cancer","volume":"221","author":"Lee","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb1355","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nchem.2917","article-title":"Engineered modular biomaterial logic gates for environmentally triggered therapeutic delivery","volume":"10","author":"Badeau","year":"2018","journal-title":"Nature Chemistry"},{"key":"10.1016\/j.jconrel.2026.115274_bb1360","doi-asserted-by":"crossref","first-page":"22968","DOI":"10.1021\/acsnano.5c02492","article-title":"Biomimetic ginsenoside Rb1 and probucol co-assembled nanoparticles for targeted atherosclerosis therapy via inhibition of oxidative stress, inflammation, and lipid deposition","volume":"19","author":"Zeng","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115274_bb1365","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.3390\/ijms26146799","article-title":"LSA-DDI: learning stereochemistry-aware drug interactions via 3D feature fusion and contrastive cross-attention","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb1370","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: an emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jconrel.2026.115274_bb1375","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s13238-018-0547-2","article-title":"Pharmacomicrobiomics: a novel route towards personalized medicine?","volume":"9","author":"Doestzada","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.jconrel.2026.115274_bb1380","article-title":"Programmable microbial therapeutics: advances in engineered bacteria for targeted in vivo delivery and precision medicine","author":"Zhao","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb1385","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41467-022-28163-5","article-title":"Genetically stable CRISPR-based kill switches for engineered microbes","volume":"13","author":"Rottinghaus","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1390","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tibtech.2021.08.002","article-title":"Discovery and delivery strategies for engineered live biotherapeutic products","volume":"40","author":"Heavey","year":"2021","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1395","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115720","article-title":"Microbiome-active drug delivery systems (MADDS): leveraging microbial stimuli for controlled drug release","volume":"227","author":"Kamath","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb1400","first-page":"402","article-title":"Cell encapsulated biomaterials for translational medicine","volume":"56","author":"Arumugam","year":"2026","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115274_bb1405","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/fermentation8030117","article-title":"Novel developments on stimuli-responsive probiotic encapsulates: from smart hydrogels to nanostructured platforms","volume":"8","author":"Garcia-Brand","year":"2022","journal-title":"Fermentation"},{"key":"10.1016\/j.jconrel.2026.115274_bb1410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.620170","article-title":"Intestinal bacteria encapsulated by biomaterials enhance immunotherapy","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1415","doi-asserted-by":"crossref","first-page":"8574","DOI":"10.1021\/acs.langmuir.8b04331","article-title":"Hybrids of polymeric capsules, lipids, and nanoparticles: thermodynamics and temperature rise at the nanoscale and emerging applications","volume":"35","author":"Parakhonskiy","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115274_bb1420","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901643","article-title":"Polymeric films for the encapsulation, storage, and tunable release of therapeutic microbes","volume":"9","author":"Qiu","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115274_bb1425","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1430","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1016\/j.apsb.2023.08.028","article-title":"Converting bacteria into autologous tumor vaccine via surface biomineralization of calcium carbonate for enhanced immunotherapy","volume":"13","author":"Guo","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115274_bb1435","doi-asserted-by":"crossref","DOI":"10.1080\/20002297.2025.2453964","article-title":"Oral Fusobacterium nucleatum resists the acidic pH of the stomach due to membrane erucic acid synthesized via enoyl-CoA hydratase-related protein FnFabM","volume":"17","author":"Li","year":"2025","journal-title":"J. Oral Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1440","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fmed.2017.00163","article-title":"Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts","volume":"4","author":"Urdaneta","year":"2017","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.jconrel.2026.115274_bb1445","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/fermentation8030117","article-title":"Novel developments on stimuli-responsive probiotic encapsulates: from smart hydrogels to nanostructured platforms","volume":"8","author":"Garcia-Brand","year":"2022","journal-title":"Fermentation"},{"key":"10.1016\/j.jconrel.2026.115274_bb1450","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1016\/j.apsb.2025.07.028","article-title":"Progress and challenges of functionalized bacterial encapsulation: a novel biotechnology for next-generation biotherapeutics","volume":"15","author":"Zhang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115274_bb1455","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201807909","article-title":"Mechanically-activated microcapsules for \u201con-demand\u201d drug delivery in dynamically loaded musculoskeletal tissues","volume":"29","author":"Mohanraj","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115274_bb1460","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.addr.2012.01.003","article-title":"Engineering nanomedicines using stimuli-responsive biomaterials","volume":"64","author":"Wang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb1465","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jconrel.2026.115274_bb1470","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s44320-024-00067-0","article-title":"Bacterial live therapeutics for human diseases","volume":"20","author":"Frutos-Grilo","year":"2024","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1475","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.aninu.2020.09.002","article-title":"Interplay between gut microbiota and antimicrobial peptides","volume":"6","author":"Zong","year":"2020","journal-title":"Anim. Nutr."},{"key":"10.1016\/j.jconrel.2026.115274_bb1480","article-title":"Surface engineering Salmonella with pH-responsive polyserotonin and self-activated DNAzyme for better microbial therapy of tumor","volume":"3","author":"Guo","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2026.115274_bb1485","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb1490","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/acs.nanolett.0c03811","article-title":"\u201cTrojan Horse\u201d Salmonella enabling tumor homing of silver nanoparticles via neutrophil infiltration for synergistic tumor therapy and enhanced biosafety","volume":"21","author":"Mi","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115274_bb1495","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/bios15090556","article-title":"Synthetic gene circuits enable sensing in engineered living materials","volume":"15","author":"Cai","year":"2025","journal-title":"Biosensors"},{"key":"10.1016\/j.jconrel.2026.115274_bb1500","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20240045","article-title":"Synthetic biology-based engineering living therapeutics for antimicrobial application","volume":"5","author":"Huang","year":"2025","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2026.115274_bb1505","doi-asserted-by":"crossref","first-page":"8744","DOI":"10.3390\/ijms21228744","article-title":"Synthetic biology approaches in the development of engineered therapeutic microbes","volume":"21","author":"Kang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb1510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/gels9010039","article-title":"Alginate hydrogels reinforced by dehydration under stress\u2014application to a soft magnetic actuator","volume":"9","author":"Leon-Cecilla","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.jconrel.2026.115274_bb1515","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.201900287","article-title":"Zwitterionic polymer coating suppresses microglial encapsulation to neural implants in vitro and in vivo","volume":"4","author":"Yang","year":"2020","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.jconrel.2026.115274_bb1520","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3504","article-title":"Optimizing cryopreservation strategies for scalable cell therapies: a comprehensive review with insights from iPSC-derived therapies","volume":"40","author":"Dobruskin","year":"2024","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jconrel.2026.115274_bb1525","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1039\/D4MD00174E","article-title":"Trehalose in cryopreservation. Applications, mechanisms and intracellular delivery opportunities","volume":"15","author":"Murray","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115274_bb1530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105837","article-title":"Inflammation-modulating polymeric nanoparticles: design strategies, mechanisms, and therapeutic applications","volume":"118","author":"Zhang","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jconrel.2026.115274_bb1535","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12934-020-01465-3","article-title":"Efficient protection of microorganisms for delivery to the intestinal tract by cellulose sulphate encapsulation","volume":"19","author":"Gunzburg","year":"2020","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.jconrel.2026.115274_bb1540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.07.014","article-title":"Polymeric carriers for enhanced delivery of probiotics","volume":"161\u2013162","author":"Asgari","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb1545","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1631\/jzus.B1400290","article-title":"A simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestine","volume":"16","author":"Miller","year":"2015","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.jconrel.2026.115274_bb1550","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1038\/s41467-025-59172-9","article-title":"Acid-resistant chemotactic DNA micromotors for probiotic delivery in inflammatory bowel disease","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1555","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.959441","article-title":"Achieving spatially precise diagnosis and therapy in the mammalian gut using synthetic microbial gene circuits","volume":"10","author":"Robinson","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1560","first-page":"293","article-title":"Tumour-resident oncolytic bacteria trigger potent anticancer effects through selective intratumoural thrombosis and necrosis, Nature","volume":"10","author":"Iwata","year":"2025","journal-title":"Biomedical Engineering"},{"key":"10.1016\/j.jconrel.2026.115274_bb1565","article-title":"HYDRHA: hydrogels of hyaluronic acid. New biomedical approaches in cancer, neurodegenerative diseases, and tissue engineering","volume":"17","author":"Grieco","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb1570","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119226","article-title":"Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy","volume":"214","author":"Chen","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115274_bb1575","article-title":"A syringeable immunotherapeutic hydrogel enhances T cell immunity via in-situ activation of STING pathway for advanced breast cancer postoperative therapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1580","doi-asserted-by":"crossref","DOI":"10.3389\/fchbi.2024.1386220","article-title":"Putting the sting back in STING therapy: novel delivery vehicles for improved STING activation","volume":"3","author":"Khorsandi","year":"2024","journal-title":"Front. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1585","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.2147\/IJN.S483815","article-title":"Photo-thermally controllable tumor metabolic modulation to assist T cell activation for boosting immunotherapy","volume":"19","author":"Ma","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115274_bb1590","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4236\/jct.2013.41035","article-title":"PLGA-polymer encapsulating tumor antigen and CpG DNA administered into the tumor microenvironment elicits a systemic antigen-specific IFN-\u03b3 response and enhances survival","volume":"4","author":"Nikitczuk","year":"2013","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb1595","article-title":"Enhancing drug bioavailability through mucoadhesive technologies: a comprehensive review of delivery systems","author":"Desai","year":"2025","journal-title":"Biomed. Mater. Devices"},{"key":"10.1016\/j.jconrel.2026.115274_bb1600","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0016-5085(99)70013-2","article-title":"Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice","volume":"116","author":"Madsen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2026.115274_bb1605","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1021\/acsbiomaterials.5c00986","article-title":"Electrosprayed micro-to-nanoscale particles with tunable morphologies and compositions for pulmonary drug delivery applications and inhalation therapies: a review","volume":"11","author":"Wang","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.115274_bb1610","article-title":"Microenvironment-sensitive hydrogels as promising drug delivery systems for co-encapsulating microbial homeostasis probiotics and anti-inflammatory drugs to treat periodontitis","volume":"32","author":"Quan","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115274_bb1615","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2147\/DDDT.S467835","article-title":"Development of intratumoral drug delivery based strategies for antitumor therapy","volume":"18","author":"Jiang","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb1620","article-title":"Enabling targeted drug delivery for treatment of ulcerative colitis with mucosal-adhesive photoreactive hydrogel","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb1625","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115663","article-title":"Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products","volume":"225","author":"Brittain","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115274_bb1630","first-page":"197","article-title":"Structural and biological engineering of 3D hydrogels for wound healing","volume":"24","author":"Norahan","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115274_bb1635","article-title":"Recent advances of engineered bacteria for therapeutic applications","author":"Xiang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115274_bb1640","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1669399","article-title":"Smart biomaterials: as active immune modulators to shape pro-regenerative microenvironments","volume":"13","author":"Zhang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1645","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fbioe.2020.00130","article-title":"Electrospun nanofibers as carriers of microorganisms, stem cells, proteins, and nucleic acids in therapeutic and other applications","volume":"8","author":"Stojanov","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1650","doi-asserted-by":"crossref","first-page":"40326","DOI":"10.1021\/acsami.5c11155","article-title":"Controlled release of microorganisms from engineered living materials","volume":"17","author":"Kalairaj","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115274_bb1655","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115274_bb1660","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41385-022-00564-1","article-title":"Microbiome-based interventions to modulate gut ecology and the immune system","volume":"15","author":"Hitch","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1665","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/pharmaceutics17050606","article-title":"Enzyme-based anti-inflammatory therapeutics for inflammatory diseases","volume":"17","author":"Narayanan","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115274_bb1670","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.tim.2023.08.001","article-title":"Programming therapeutic probiotics by self-tunable sense-and-respond genetic circuits","volume":"31","author":"Liu","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1675","first-page":"545","article-title":"Imaging techniques for probiotic tracking and localization, advances in probiotic delivery systems: strategies for enhanced viability","author":"Gupta","year":"2025","journal-title":"Targeted Delivery and Efficacy"},{"key":"10.1016\/j.jconrel.2026.115274_bb1680","doi-asserted-by":"crossref","first-page":"18234","DOI":"10.1021\/acs.jafc.4c00182","article-title":"Systems metabolic engineering to elucidate and enhance intestinal metabolic activities of Escherichia coli Nissle 1917","volume":"72","author":"Kim","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2026.115274_bb1685","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1034205","article-title":"Hypoxia induced lactate acidosis modulates tumor microenvironment and lipid reprogramming to sustain the cancer cell survival","volume":"13","author":"Singh","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1690","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1000873","article-title":"Microbiome engineering: engineered live biotherapeutic products for treating human disease","volume":"10","author":"Rutter","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1695","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-025-01766-3","article-title":"Engineering bacteria for enhanced tumor therapy: from surface modification to synthetic genetic circuits","author":"Wang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1700","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1710880","article-title":"Gut microbiota\u2013derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1705","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an engineered E. coli Nissle strain expressing STING agonist, with and without Atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb1710","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jconrel.2025.02.064","article-title":"Tumor-stromal opening via S. typhimurium VNP20009 administration for complete inhibition of refractory tumor growth with liposomal anticancer drugs","volume":"380","author":"Kato","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115274_bb1715","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41591-022-01683-9","article-title":"Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b\/2a trial","volume":"28","author":"Stewart Campbell","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb1720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280499","article-title":"Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster","volume":"18","author":"Kalantari","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115274_bb1725","first-page":"1685","article-title":"Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial, Nature","volume":"5","author":"Vockley","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.jconrel.2026.115274_bb1730","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1038\/s41467-021-26524-0","article-title":"Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering","volume":"12","author":"Adolfsen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1735","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.2023.4314","article-title":"VE303, a defined bacterial consortium, for prevention of recurrent clostridioides difficile infection: a randomized clinical trial","volume":"329","author":"Louie","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2026.115274_bb1740","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.chom.2022.03.016","article-title":"Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers","volume":"30","author":"Dsouza","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.115274_bb1745","article-title":"Primary and secondary immune checkpoint inhibitors resistance in colorectal cancer: key mechanisms and ways to overcome resistance","volume":"33","author":"Abushukair","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1750","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41467-024-55751-4","article-title":"Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung","volume":"16","author":"Zhu","year":"2025","journal-title":"Nature Communications"},{"key":"10.1016\/j.jconrel.2026.115274_bb1755","first-page":"613","article-title":"Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery, Nature","volume":"10","author":"Murad","year":"2025","journal-title":"Biomedical Engineering"},{"key":"10.1016\/j.jconrel.2026.115274_bb1760","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1158\/1078-0432.CCR-19-0070","article-title":"Clinical response of live-attenuated, Listeria monocytogenes expressing mesothelin (CRS-207) with chemotherapy in patients with malignant pleural mesothelioma","volume":"25","author":"Hassan","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115274_bb1765","doi-asserted-by":"crossref","first-page":"P68","DOI":"10.1186\/2051-1426-2-S3-P68","article-title":"A phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)","volume":"2","author":"Wang-Gillam","year":"2014","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115274_bb1770","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4161\/hv.28549","article-title":"Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation","volume":"10","author":"Mart\u00edn","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2026.115274_bb1775","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiaa779","article-title":"Opportunities and challenges in development of live biotherapeutic products to fight infections","volume":"223","author":"Ducarmon","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jconrel.2026.115274_bb1780","doi-asserted-by":"crossref","DOI":"10.4014\/jmb.2410.10054","article-title":"Live biotherapeutic products for metabolic diseases: development strategies, challenges, and future directions","volume":"35","author":"Min","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1785","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s12276-020-0437-6","article-title":"Live biotherapeutic products: the importance of a defined regulatory framework","volume":"52","author":"Cordaillat-Simmons","year":"2020","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/j.jconrel.2026.115274_bb1790","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.cmet.2025.10.017","article-title":"Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD","volume":"37","author":"Long","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2026.115274_bb1795","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113664","article-title":"Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering","volume":"382","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115274_bb1800","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155258","article-title":"Inhibition of inflammation by berberine: molecular mechanism and network pharmacology analysis","volume":"128","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2026.115274_bb1805","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S466042","article-title":"Tumor cell-targeting and tumor microenvironment-responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/Chemodynamic treatment of cervical cancer","volume":"19","author":"Wang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115274_bb1810","first-page":"799","article-title":"Recent trends and advances in microbe-based drug delivery systems, DARU","volume":"27","author":"Shende","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115274_bb1815","series-title":"Infections in Immunocompromised Hosts, ICU Protocols: A Step-Wise Approach","first-page":"667","volume":"I","author":"Rege","year":"2025"},{"key":"10.1016\/j.jconrel.2026.115274_bb1820","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2023.03.017","article-title":"Horizontal gene transfer among host-associated microbes","volume":"31","author":"Moura de Sousa","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.115274_bb1825","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108192","article-title":"Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy","volume":"34","author":"Dong","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.115274_bb1830","article-title":"Harnessing bacteria for tumor therapy: current advances and challenges","volume":"35","author":"Guo","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.115274_bb1835","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41467-021-21740-0","article-title":"Applications, challenges, and needs for employing synthetic biology beyond the lab","volume":"12","author":"Brooks","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1840","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/sb500258b","article-title":"Synthetic microbes as drug delivery systems","volume":"4","author":"Claesen","year":"2014","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1845","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac006","article-title":"Biomedical data, computational methods and tools for evaluating disease\u2013disease associations","volume":"23","author":"Xiang","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.jconrel.2026.115274_bb1850","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2217076","article-title":"Sweet syndrome induced by SARS-CoV-2 vaccines: a systematic review of patient-report studies","volume":"19","author":"Jia","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2026.115274_bb1855","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1267378","article-title":"Systems and synthetic biology-driven engineering of live bacterial therapeutics","volume":"11","author":"Kim","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1860","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115274_bb1865","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.6026\/973206300211158","article-title":"A framework for biosafety assessment of microbial strains in biotechnology applications","volume":"21","author":"Shrivastava","year":"2025","journal-title":"Bioinformation"},{"key":"10.1016\/j.jconrel.2026.115274_bb1870","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1021\/acsmaterialslett.5c00238","article-title":"Biocircuitry and living programmable materials: the next frontier in synthetic living systems","volume":"7","author":"Morones-Ram\u00edrez","year":"2025","journal-title":"ACS Mater. Lett."},{"key":"10.1016\/j.jconrel.2026.115274_bb1875","article-title":"Synthetic genomes unveil the effects of synonymous recoding","author":"Nyerges","year":"2024","journal-title":"BioRxiv"},{"key":"10.1016\/j.jconrel.2026.115274_bb1880","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108028","article-title":"Unlocking the bacterial domain for industrial biotechnology applications using universal parts and tools","volume":"60","author":"De Wannemaeker","year":"2022","journal-title":"Biotechnol. Adv."},{"issue":"2018","key":"10.1016\/j.jconrel.2026.115274_bb1885","first-page":"915","article-title":"An ingestible bacterial-electronic system to monitor gastrointestinal health","volume":"360","author":"Mimee","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115274_bb1890","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s12276-020-0437-6","article-title":"Live biotherapeutic products: the importance of a defined regulatory framework","volume":"52","author":"Cordaillat-Simmons","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115274_bb1895","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/biot.201300119","article-title":"Microbial heterogeneity affects bioprocess robustness: dynamic single-cell analysis contributes to understanding of microbial populations","volume":"9","author":"Delvigne","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2026.115274_bb1900","doi-asserted-by":"crossref","DOI":"10.1093\/jimb\/kuad033","article-title":"Diverse mechanisms of bioproduction heterogeneity in fermentation and their control strategies","volume":"50","author":"Mu","year":"2023","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1905","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1186224","article-title":"Potency assays and biomarkers for cell-based advanced therapy medicinal products","volume":"14","author":"Capelli","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1910","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3389\/fphar.2019.00921","article-title":"Regulatory framework for advanced therapy medicinal products in Europe and United States","volume":"10","author":"Iglesias-L\u00f3pez","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115274_bb1915","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrd3974","article-title":"Challenges and approaches for the development of safer immunomodulatory biologics","volume":"12","author":"Sathish","year":"2013","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:14:55Z","timestamp":1793337295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926006784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":383,"alternative-id":["S0168365926006784"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115274","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Living drug carriers: Microbial and bioengineered platforms redefining precision therapeutic and immunomodulatory delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115274"}}